Pfizer and BioNTech have begun a clinical trial for an Omicron-specific Covid-19 vaccine candidate. But Dr. Luis Schang, a virologist at Cornell University, says while it makes sense to develop a specific vaccine against Omicron, we should not lose sight of what is already available.

Health, Nutrition & Medicine

Life Sciences & Veterinary Medicine

science

---

Pfizer announced vaccinated children, aged 5 to 11, showed evidence of protection against the coronavirus.

science

Health, Nutrition & Medicine

---

Luis Schang says the benefits of returning to a more open society now outweigh the marginal risk of vaccinated people not wearing masks and distancing.

Life Sciences & Veterinary Medicine

---

Luis Schang, a molecular virologist who studies the interactions between viruses and cells, says despite the concerns, this is likely the most careful worldwide vaccination campaign ever performed, and that suspending AstraZeneca vaccinations may lead to more blood clots — a common side effect of severe COVID-19.

Health, Nutrition & Medicine

---

Cornell experts are available to discuss the potential of a coronavirus vaccine from multiple angles, including the science of vaccines, why people choose not to be vaccinated, health care systems, insurance companies and policies. 

Life Sciences & Veterinary Medicine

---